EUVIMEDEUVIMED entdecken
Open Access

Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1

Frank Krieger, Friedrich Metzger, Sibylle Jablonka

Rare Diseases · 2014-01 · 2 (1) · e29415

DOI: 10.4161/rdis.29415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rare Diseases, online erschienen am 10.06.2014. Verfasst von Frank Krieger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Neurobiology; University of Wuerzburg; Wuerzburg, Germany. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cav2.2IGF1Ighmbp2SMARD1motoneurons

Autor:innen und Institutionen

  • Institute for Clinical Neurobiology; University of Wuerzburg; Wuerzburg, Germany.
  • Roche Pharmaceutical Research and Early Development; Roche Innovation Center Basel; F. Hoffmann-La Roche Ltd.; Basel, Switzerland.

Zitieren

APA

Krieger, F., Metzger, F., & Jablonka, S. (2014). Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1. Rare Diseases, 2(1), e29415. https://doi.org/10.4161/rdis.29415

Vancouver

Krieger F, Metzger F, Jablonka S. Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1. Rare Diseases. 2014;2(1):e29415. doi:10.4161/rdis.29415

BibTeX
@article{Krieger2014,
  author = {Krieger, Frank and Metzger, Friedrich and Jablonka, Sibylle},
  title = {Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1},
  journal = {Rare Diseases},
  year = {2014},
  volume = {2},
  number = {1},
  pages = {e29415},
  doi = {10.4161/rdis.29415}
}
Kostenlos starten →